Business Context and Reporting Period
Company: BRASKEM S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: June 2026 (Filing Date: June 9, 2026)
Business Overview: Braskem is a publicly held Brazilian company headquartered in Camaçari, Bahia, listed on the Level 1 segment of B3. Its primary objectives include the manufacture, commercialization, and distribution of chemical products, petrochemicals, thermoplastic resins, and utilities. The company also engages in the production of electricity, trading of oil derivatives, and research in biotechnology and renewable sources.
Key Financial Metrics
Capital Structure:
- Authorized Capital Stock: R$ 8,043,222,080.50 (Eight billion, forty-three million, two hundred and twenty-two thousand, eighty reais and fifty cents).
- Total Shares Outstanding: 797,207,834 shares.
- Share Composition:
- Common Shares: 451,668,652
- Class "A" Preferred Shares: 345,060,392
- Class "B" Preferred Shares: 478,790
- Authorized Capital Increase: The Board is authorized to increase capital stock up to 1,152,937,970 shares.
Financial Performance Data:
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity for the period ended June 30, 2026. This document contains the Company's Bylaws and governance structure rather than financial statements.
Material Changes
The filing does not report material changes in financial performance or operations compared to prior periods. The document serves to update the SEC on the Company's Bylaws and governance framework as of June 2026.
Guidance, Outlook, and Risks
Dividend Policy:
- Mandatory Dividend: Shareholders are entitled to a mandatory dividend of 25% of the net income for the financial year.
- Preferred Shares: Class "A" and "B" preferred shares have priority for a minimum, non-cumulative dividend of 6% of their unit value. Class "A" shares participate equally with common shares in remaining income distribution after the 6% minimum is met; Class "B" shares do not participate in remaining income.
- Interim Dividends: The Board of Directors may declare interim dividends based on positive net income in monthly, quarterly, or half-yearly statements.
Risks and Contingencies (Forward-Looking Statements):
The filing includes a disclaimer noting that forward-looking statements are subject to risks and uncertainties, specifically citing:
- The potential impact of a geological event in Alagoas and related legal proceedings.
- The impact of the COVID-19 pandemic on business, employees, and stakeholders.
- General economic and market conditions.
Governance and Authority Limits:
- Board of Directors: Composed of 11 members (including 3 independent directors). They must approve operational investments exceeding R$ 240 million, asset acquisitions exceeding 1% of non-current assets or R$ 350 million, and related-party transactions exceeding R$ 30 million per operation.
- Executive Board: Composed of 8 officers. They manage day-to-day operations and have authority limits lower than the Board (e.g., investments up to R$ 240 million).
- Tag-Along Rights: All shares are entitled to tag-along rights in the event of a transfer of control, ensuring minority shareholders receive the same price per share as the controlling shareholder.
Investor Verification Checklist
- Financial Statements: Verify the actual revenue, profit, and cash flow figures for the period ended June 30, 2026, as they are not included in this Bylaws filing.
- Geological Event Impact: Investigate the current status and financial implications of the "geological event in Alagoas" mentioned in the risk disclaimer.
- Capital Increases: Monitor for any Board resolutions exercising the authority to increase capital stock up to the authorized limit of 1,152,937,970 shares.
- Dividend Declarations: Confirm if interim dividends have been declared for the first half of 2026 based on the 25% mandatory policy.
- Related Party Transactions: Review disclosures for any related-party transactions exceeding the R$ 30 million threshold requiring Board approval.